The Recession Is Already Here – 7 Goldman Sachs Conviction List Dividend Stocks Can Survive24/7 Wall Street • 07/25/22
Long-Term Revenue Projections Suggest Merck Will Survive, Even Thrive, After Keytruda LOESeeking Alpha • 07/20/22
Merck Provides Update on Phase 3 KEYNOTE-412 Trial in Unresected Locally Advanced Head and Neck Squamous Cell CarcinomaBusiness Wire • 07/20/22
Is Merck Stock A Buy With A Possible Seagen Buyout Right Around The Corner?Investors Business Daily • 07/19/22
Merck & AstraZeneca Partnered Lynparza Fails In Late-Stage Colorectal Cancer StudyBenzinga • 07/19/22
Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources sayMarket Watch • 07/15/22
Merck to pay Orion $290 million upfront to develop, commercialize prostate cancer treatmentMarket Watch • 07/13/22
Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate CancerBusiness Wire • 07/13/22